Axsome Therapeutics (AXSM) PT Lowered to $123 at RBC Capital
Tweet
Share
E-mailGet Alerts AXSM Hot Sheet
Price: $213.67 --0%
Rating Summary:
26 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
26 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
RBC Capital analyst Leonid Timashev lowered the price target on Axsome Therapeutics (NASDAQ: AXSM) to $123.00 (from $126.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Axsome Therapeutics (AXSM) PT Raised to $316 at Mizuho
- Axsome Therapeutics (AXSM) PT Raised to $268 at Needham
- LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
